# Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

> **NCT03345420** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 102 (actual)

## Conditions studied

- Ductal Breast Carcinoma In Situ
- Invasive Breast Carcinoma
- Stage 0 Breast Cancer
- Stage I Breast Cancer
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage II Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy

## Key facts

- **NCT ID:** NCT03345420
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-12
- **Primary completion:** 2022-08-30
- **Final completion:** 2025-06-26
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345420, "Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03345420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*